MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,355,404 | +184.6% | 145,900 | +136.1% | 0.10% | +151.3% |
| Q2 2023 | $2,232,834 | -89.7% | 61,800 | -87.1% | 0.04% | -88.5% |
| Q4 2022 | $21,726,145 | -31.5% | 479,500 | +5.6% | 0.34% | -22.6% |
| Q3 2022 | $31,724,000 | +413.7% | 454,239 | +393.7% | 0.44% | +409.3% |
| Q2 2022 | $6,176,000 | +583.2% | 92,000 | +736.4% | 0.09% | +681.8% |
| Q1 2022 | $904,000 | -97.1% | 11,000 | -94.9% | 0.01% | -96.9% |
| Q4 2021 | $31,583,000 | -61.0% | 215,296 | -53.0% | 0.35% | -61.8% |
| Q3 2021 | $81,010,000 | +720.9% | 457,911 | +649.4% | 0.93% | +617.8% |
| Q2 2021 | $9,869,000 | -42.0% | 61,100 | -38.5% | 0.13% | -64.7% |
| Q1 2021 | $17,010,000 | +17.3% | 99,300 | +50.4% | 0.36% | +10.6% |
| Q4 2020 | $14,502,000 | -39.7% | 66,025 | -54.4% | 0.33% | -41.3% |
| Q3 2020 | $24,049,000 | +134.0% | 144,840 | +60.9% | 0.56% | +64.3% |
| Q2 2020 | $10,277,000 | -43.7% | 90,000 | -62.1% | 0.34% | -66.9% |
| Q1 2020 | $18,239,000 | -48.3% | 237,300 | -13.3% | 1.03% | -12.8% |
| Q4 2019 | $35,255,000 | +189.4% | 273,600 | +75.0% | 1.18% | +86.8% |
| Q3 2019 | $12,180,000 | -55.9% | 156,300 | -41.8% | 0.63% | -54.5% |
| Q2 2019 | $27,645,000 | +840.6% | 268,400 | +569.3% | 1.39% | +759.3% |
| Q1 2019 | $2,939,000 | +133.8% | 40,100 | +50.2% | 0.16% | +134.8% |
| Q3 2018 | $1,257,000 | – | 26,700 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |